The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update
Abstract
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaws (MRONJ) - formerly referred to as bisphosphonate-related osteonecrosis of the jaws (BRONJ)-were set forth in the American Association of Oral and Maxillofacial Surgeons (AAOMS) position papers in 2007, 2009 and 2014. The position papers were developed by a committee appointed by the AAOMS Board of Trustees and comprising clinicians with extensive experience in caring for these patients, as well as clinical and basic science researchers. The knowledge base and experience in addressing MRONJ continues to evolve and expand, necessitating modifications and refinements to the previous position papers. Three members of the AAOMS Committee on Oral, Head, and Neck Oncologic and Reconstructive Surgery (COHNORS) and three authors of the 2014 position paper were appointed to serve as a working group to analyze the current literature and revise the guidance as indicated to reflect current knowledge in this field. This update contains revisions to diagnosis and management strategies and highlights the current research status. AAOMS maintains that it is vitally important for this information to be disseminated to other relevant healthcare professionals and organizations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., Delmas, P., Zoog, H. B., Austin, M., Wang, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809493 · Cited by 3,489
Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067312 · Cited by 2,986
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.031 · Cited by 2,905
Self-citationFizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
Cosman, F., Crittenden, D. B., Adachi, J. D., Binkley, N., Czerwinski, E., Ferrari, S., Hofbauer, L. C., Lau, E., Lewiecki, E. M., Miyauchi, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607948 · Cited by 1,805
Black, D. M., & Rosen, C. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1513724 · Cited by 1,712
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Marx, R. E., Sawatari, Y., Fortin, M., & Broumand, V. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.010 · Cited by 1,648
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Saag, K. G., Petersen, J., Brandi, M. L., Karaplis, A. C., Lorentzon, M., Thomas, T., Maddox, J., Fan, M., Meisner, P. D., & Grauer, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708322 · Cited by 1,544
Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2405 · Cited by 1,353
Self-citationOsteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors
Bamias, A., Kastritis, E., Bamia, C., Moulopoulos, L. A., Melakopoulos, I., Bozas, G., Koutsoukou, V., Gika, D., Anagnostopoulos, A., Papadimitriou, C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8670 · Cited by 1,149
Efficacy of Pamidronate in Reducing Skeletal Events in Patients with Advanced Multiple Myeloma
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M. J., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340802 · Cited by 1,081
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30138-9 · Cited by 996
Hypercalcemia Associated with Cancer
Stewart, A. F. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp042806 · Cited by 973
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.
Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854
(2007) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2006.11.003 · Cited by 837
Osteonecrosis of the Jaw and Bisphosphonates
(2005) · New England Journal of Medicine · doi:10.1056/nejm200507073530120 · Cited by 744
Cummings, S. R., Ferrari, S., Eastell, R., Gilchrist, N., Jensen, J.-E. B., McClung, M., Roux, C., Törring, O., Valter, I., Wang, A. T., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3337 · Cited by 734
A quantitative system for staging avascular necrosis
Steinberg, M. E., HAYKEN, G. D., & Steinberg, D. (1995) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.77b1.7822393 · Cited by 731
Rosen, L. S., Gordon, D., Tchekmedyian, S., Yanagihara, R., Hirsh, V., Krzakowski, M., Pawlicki, M., de Souza, P., Zheng, M., Urbanowitz, G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.105 · Cited by 729
Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martin, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 694
Berenson, J. R., Lichtenstein, A., Porter, L., Dimopoulos, M. A., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.593 · Cited by 648
Hoff, A. O., Toth, B. B., Altundag, K., Johnson, M. M., Warneke, C. L., Hu, M., Nooka, A., Sayegh, G., Guarneri, V., Desrouleaux, K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080205 · Cited by 633
Hortobagyi, G. N., Theriault, R. L., Lipton, A., Porter, L., Blayney, D., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J. J., Knight, R. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2038 · Cited by 631
Johnston, C. B., & Dagar, M. (2020) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.06.004 · Cited by 615
Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors
Badros, A., Weikel, D., Salama, A., Goloubeva, O., Schneider, A., Rapoport, A., Fenton, R., Gahres, N., Sausville, E., Ord, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2465 · Cited by 593
Chawla, S., Henshaw, R., Seeger, L., Choy, E., Blay, J.-Y., Ferrari, S., Kroep, J., Grimer, R., Reichardt, P., Rutkowski, P., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70277-8 · Cited by 587
Gnant, M., Pfeiler, G., Dubsky, P. C., Hubalek, M., Greil, R., Jakesz, R., Wette, V., Balic, M., Haslbauer, F., Melbinger, E., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60995-3 · Cited by 559
Berenson, J. R., Hillner, B. E., Kyle, R. A., Anderson, K., Lipton, A., Yee, G. C., & Biermann, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.037 · Cited by 542
Coleman, R. E., Major, P., Lipton, A., Brown, J. E., Lee, K.-A., Smith, M., Saad, F., Zheng, M., Hei, Y. J., Seaman, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.091 · Cited by 533
Ruggiero, S. L., Dodson, T. B., Assael, L. A., Landesberg, R., Marx, R. E., & Mehrotra, B. (2009) · Australian Endodontic Journal · doi:10.1111/j.1747-4477.2009.00213.x · Cited by 505
Self-citationTsourdi, E., Langdahl, B., Cohen-Solal, M., Aubry-Rozier, B., Eriksen, E. F., Guañabens, N., Obermayer-Pietsch, B., Ralston, S. H., Eastell, R., & Zillikens, M. C. (2017) · Bone · doi:10.1016/j.bone.2017.08.003 · Cited by 504
Mortality after osteoporotic hip fracture: incidence, trends, and associated factors
Guzon-Illescas, O., Perez Fernandez, E., Crespí Villarias, N., Quirós Donate, F. J., Peña, M., Alonso-Blas, C., García-Vadillo, A., & Mazzucchelli, R. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1226-6 · Cited by 495
Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Lo, J. C., O'Ryan, F. S., Gordon, N. P., Yang, J., Hui, R. L., Martin, D., Hutchinson, M., Lathon, P. V., Sanchez, G., Silver, P., et al. (2010) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.03.050 · Cited by 493
Migliorati, C. A., Schubert, M. M., Peterson, D. E., & Seneda, L. M. (2005) · Cancer · doi:10.1002/cncr.21130 · Cited by 489
Raje, N., Terpos, E., Willenbacher, W., Shimizu, K., García-Sanz, R., Durie, B., Legieć, W., Krejčí, M., Laribi, K., Zhu, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30072-x · Cited by 449
II. Meta-Analysis of Alendronate for the Treatment of Postmenopausal Women
Cranney, A., Wells, G., Willan, A., Griffith, L., Zytaruk, N., Robinson, V., Black, D., Adachi, J., Shea, B., Tugwell, P., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-2002 · Cited by 445
Dimopoulos, M. A., Kastritis, E., Bamia, C., Melakopoulos, I., Gika, D., Roussou, M., Migkou, M., Eleftherakis-Papaiakovou, E., Christoulas, D., Terpos, E., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn554 · Cited by 437
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
Yarom, N., Shapiro, C. L., Peterson, D. E., Van Poznak, C. H., Bohlke, K., Ruggiero, S. L., Migliorati, C. A., Khan, A., Morrison, A., Anderson, H., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01186 · Cited by 420
Self-citationRipamonti, C. I., Maniezzo, M., Campa, T., Fagnoni, E., Brunelli, C., Saibene, G., Bareggi, C., Ascani, L., & Cislaghi, E. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn526 · Cited by 405
Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment
Petek, D., Hannouche, D., & Suva, D. (2019) · EFORT Open Reviews · doi:10.1302/2058-5241.4.180036 · Cited by 399
Anastasilakis, A. D., Polyzos, S. A., Makras, P., Aubry‐Rozier, B., Kaouri, S., & Lamy, O. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3110 · Cited by 371
Hansen, T., Kunkel, M., Weber, A., & James Kirkpatrick, C. (2006) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2006.00391.x · Cited by 368
Hellstein, J. W., Adler, R. A., Edwards, B., Jacobsen, P. L., Kalmar, J. R., Koka, S., Migliorati, C. A., & Ristic, H. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0108 · Cited by 363
Himelstein, A. L., Foster, J. C., Khatcheressian, J. L., Roberts, J. D., Seisler, D. K., Novotny, P. J., Qin, R., Go, R. S., Grubbs, S. S., O’Connor, T., et al. (2017) · JAMA · doi:10.1001/jama.2016.19425 · Cited by 356
Bisphosphonates and other bone agents for breast cancer
O'Carrigan, B., Wong, M. H., Willson, M. L., Stockler, M. R., Pavlakis, N., & Goodwin, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003474.pub4 · Cited by 356
Santini, D., Vincenzi, B., Dicuonzo, G., Avvisati, G., Massacesi, C., Battistoni, F., Gavasci, M., Rocci, L., Tirindelli, M. C., Altomare, V., et al. (2003) · PubMed · Cited by 350
Papapoulos, S., Chapurlat, R., Libanati, C., Brandi, M. L., Brown, J. P., Czerwiński, E., Krieg, M.-A., Man, Z., Mellström, D., Radominski, S. C., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1479 · Cited by 344
Dimopoulos, M. A., Kastritis, E., Anagnostopoulos, A., Melakopoulos, I., Gika, D., Moulopoulos, L. A., Bamia, C., Terpos, E., Tsionos, K., & Bamias, A. (2006) · PubMed · Cited by 340
Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Knauer, M., Moik, M., Jakesz, R., Seifert, M., Taucher, S., Bjelic-Radisic, V., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu544 · Cited by 312
Japanese Allied Committee on Osteonecrosis of the Jaw, Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., Urade, M., et al. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-016-0810-7 · Cited by 308
Coleman, R., Cameron, D., Dodwell, D., Bell, R., Wilson, C., Rathbone, E., Keane, M., Gil, M., Burkinshaw, R., Grieve, R., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70302-x · Cited by 300
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
Filleul, O., Crompot, E., & Saussez, S. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0907-7 · Cited by 295
Hip fracture trends in the United States, 2002 to 2015
Michael Lewiecki, E., Wright, N. C., Curtis, J. R., Siris, E., Gagel, R. F., Saag, K. G., Singer, A. J., Steven, P. M., & Adler, R. A. (2018) · Osteoporosis International · doi:10.1007/s00198-017-4345-0 · Cited by 279
The Management of Paget's Disease of Bone
Delmas, P. D., & Meunier, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360807 · Cited by 277
Khan, A. A., Morrison, A., Kendler, D. L., Rizzoli, R., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., et al. (2017) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2016.09.005 · Cited by 264
Self-citationRisk factors for medication‐related osteonecrosis of the jaws: A systematic review
McGowan, K., McGowan, T., & Ivanovski, S. (2018) · Oral Diseases · doi:10.1111/odi.12708 · Cited by 264
Coleman, R., Finkelstein, D. M., Barrios, C., Martin, M., Iwata, H., Hegg, R., Glaspy, J., Periañez, A. M., Tonkin, K., Deleu, I., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30687-4 · Cited by 261
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study
Chawla, S. P., Blay, J., Rutkowski, P. L., Cesne, A. L., Reichardt, P., Gelderblom, H. A. J., Grimer, R. J., Choy, E., Skubitz, K. M., Seeger, L. L., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30663-1 · Cited by 255
Black, D. M., Reid, I. R., Cauley, J. A., Cosman, F., Leung, P. C., Lakatos, P., Lippuner, K., Cummings, S. R., Hue, T. F., Mukhopadhyay, A., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2442 · Cited by 253
Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat
Aghaloo, T. L., Kang, B., Sung, E. C., Shoff, M., Ronconi, M., Gotcher, J. E., Bezouglaia, O., Dry, S. M., & Tetradis, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.379 · Cited by 246
Self-citationSarasquete, M. E., García-Sanz, R., Marín, L., Alcoceba, M., Chillón, M. C., Balanzategui, A., Santamaria, C., Rosiñol, L., de la Rubia, J., Hernandez, M. T., et al. (2008) · Blood · doi:10.1182/blood-2008-04-147884 · Cited by 238
Letocha, A. D., Cintas, H. L., Troendle, J. F., Reynolds, J. C., Cann, C. E., Chernoff, E. J., Hill, S. C., Gerber, L. H., & Marini, J. C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050109 · Cited by 217
Interventions for managing medication-related osteonecrosis of the jaw
Beth-Tasdogan, N. H., Mayer, B., Hussein, H., & Zolk, O. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012432.pub2 · Cited by 211
Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment
Ficarra, G., Beninati, F., Rubino, I., Vannucchi, A., Longo, G., Tonelli, P., & Pini Prato, G. (2005) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00842.x · Cited by 210
Qi, W.-X., Tang, L.-N., He, A.-N., Yao, Y., & Shen, Z. (2014) · International Journal of Clinical Oncology · doi:10.1007/s10147-013-0561-6 · Cited by 204
Limones, Á., Sáez-Alcaide, L., Díaz-Parreño, S., Helm, A., Bornstein, M. M., & Molinero‐Mourelle, P. (2020) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.23324 · Cited by 199
Pathophysiology of Osteonecrosis of the Jaws
Aghaloo, T., Hazboun, R., & Tetradis, S. (2015) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2015.06.001 · Cited by 197
Self-citationYamazaki, T., Yamori, M., Ishizaki, T., Asai, K., Goto, K., Takahashi, K., Nakayama, T., & Bessho, K. (2012) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2012.06.020 · Cited by 193
Angiogenic factors as potential drug target: Efficacy and limitations of anti-angiogenic therapy
Gacche, R. N., & Meshram, R. J. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.05.002 · Cited by 193
Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy
Edwards, B. J., Hellstein, J. W., Jacobsen, P. L., Kaltman, S., Mariotti, A., & Migliorati, C. A. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0110 · Cited by 188
Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., Fusco, V., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17165998 · Cited by 188
Freiberger, J. J., Padilla-Burgos, R., McGraw, T., Suliman, H. B., Kraft, K. H., Stolp, B. W., Moon, R. E., & Piantadosi, C. A. (2012) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2012.04.001 · Cited by 184
Henry, D., Vadhan-Raj, S., Hirsh, V., von Moos, R., Hungria, V., Costa, L., Woll, P. J., Scagliotti, G., Smith, G., Feng, A., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-013-2022-1 · Cited by 183
Sedghizadeh, P. P., Kumar, S. K. S., Gorur, A., Schaudinn, C., Shuler, C. F., & Costerton, J. W. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0049 · Cited by 177
Wilde, F., Heufelder, M., Winter, K., Hendricks, J., Frerich, B., Schramm, A., & Hemprich, A. (2011) · Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology · doi:10.1016/j.tripleo.2010.04.015 · Cited by 175
Bisphosphonates Cause Osteonecrosis of the Jaw-Like Disease in Mice
Bi, Y., Gao, Y., Ehirchiou, D., Cao, C., Kikuiri, T., Le, A., Shi, S., & Zhang, L. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090592 · Cited by 172
Vandone, A. M., Donadio, M., Mozzati, M., Ardine, M., Polimeni, M. A., Beatrice, S., Ciuffreda, L., & Scoletta, M. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr039 · Cited by 167
Oral Health Risk Factors for Bisphosphonate-Associated Jaw Osteonecrosis
Tsao, C., Darby, I. B., Ebeling, P. R., Walsh, K. A., O’brien-simpson, N. M., Reynolds, E. C., & Borromeo, G. L. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.02.016 · Cited by 166
Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials
Boquete‐Castro, A., Gómez‐Moreno, G., Calvo‐Guirado, J. L., Aguilar‐Salvatierra, A., & Delgado‐Ruiz, R. A. (2016) · Clinical Oral Implants Research · doi:10.1111/clr.12556 · Cited by 163
Ripamonti, C. I., Cislaghi, E., Mariani, L., & Maniezzo, M. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.01.002 · Cited by 156
Boyce, A. M., Kelly, M. H., Brillante, B. A., Kushner, H., Wientroub, S., Riminucci, M., Bianco, P., Robey, P. G., & Collins, M. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1371 · Cited by 156
Sim, I., Borromeo, G. L., Tsao, C., Hardiman, R., Hofman, M. S., Hjelle, C. P., Siddique, M. M., Cook, G., Seymour, J. F., & Ebeling, P. R. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02192 · Cited by 156
Montefusco, V., Gay, F., Spina, F., Miceli, R., Maniezzo, M., Ambrosini, M. T., Farina, L., Piva, S., Palumbo, A. P., Boccadoro, M., et al. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802483778 · Cited by 154
Denosumab: an Emerging Therapy in Pediatric Bone Disorders
Boyce, A. M. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0380-1 · Cited by 150
Aguirre, J. I., Akhter, M. P., Kimmel, D. B., Pingel, J. E., Williams, A. A., Jorgensen, M., Kesavalu, L. N., & Wronski, T. J. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1669 · Cited by 141
Periapical Disease and Bisphosphonates Induce Osteonecrosis of the Jaws in Mice
Kang, B., Cheong, S., Chaichanasakul, T., Bezouglaia, O., Atti, E., Dry, S., Pirih, F. Q. M., Aghaloo, T. L., & Tetradis, S. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1894 · Cited by 140
Self-citationOsteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment
Kwon, T., Lee, C., Park, J., Choi, S., Rijal, G., & Shin, H. (2012) · Clinical Oral Implants Research · doi:10.1111/clr.12088 · Cited by 139
Aljohani, S., Fliefel, R. M., Ihbe, J., Kühnisch, J., Ehrenfeld, M., & Otto, S. (2017) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2017.05.028 · Cited by 137
The effect of antiresorptive drugs on implant therapy: Systematic review and meta‐analysis
Stavropoulos, A., Bertl, K., Pietschmann, P., Pandis, N., Schiødt, M., & Klinge, B. (2018) · Clinical Oral Implants Research · doi:10.1111/clr.13282 · Cited by 137
Gaudin, E., Seidel, L., Baćević, M., Rompen, E., & Lambert, F. (2015) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12455 · Cited by 133
Mozzati, M., Gallesio, G., Arata, V., Pol, R., & Scoletta, M. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2011.12.004 · Cited by 131
Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis
Peddi, P., Lopez-Olivo, M. A., Pratt, G. F., & Suarez-Almazor, M. E. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.07.002 · Cited by 128
Barrett-Lee, P. J., Casbard, A. C., Abraham, J., Hood, K., Coleman, R. E., Simmonds, P., Timmins, H., Wheatley, D. A., Grieve, R., Griffiths, G. O., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70539-4 · Cited by 128
The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
Grbic, J. T., Black, D. M., Lyles, K. W., Reid, D. M., ORWOLL, E. S., McClung, M. R., Bucci-Rechtweg, C. M., & Su, G. (2010) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2010.0082 · Cited by 126
Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab—a review
King, R., Tanna, N., & Patel, V. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.11.012 · Cited by 116
Lodi, G., Sardella, A., Salis, A., Demarosi, F., Tarozzi, M., & Carrassi, A. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2009.07.068 · Cited by 115
Rutkowski, P. L., Gaston, C. L., Borkowska, A. M., Stacchiotti, S., Gelderblom, H. A. J., Baldi, G. G., Palmerini, E., Casali, P. G., Gronchi, A., Parry, M., et al. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.03.020 · Cited by 112
Watts, N. B., Grbic, J. T., Binkley, N., Papapoulos, S. E., Butler, P. W., Yin, X., Tierney, A., Wagman, R. B., & McClung, M. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01965 · Cited by 112
A Role of Oral Bacteria in Bisphosphonate-induced Osteonecrosis of the Jaw
Mawardi, H. H., Giro, G., Kajiya, M., Ohta, K., Almazrooa, S. A., AlShwaimi, E., Woo, S., Nishimura, I., & Kawai, T. (2011) · Journal of Dental Research · doi:10.1177/0022034511420430 · Cited by 111
Bisphosphonate treatment of osteoporosis
Watts, N. B. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00069-1 · Cited by 111
Sivolella, S., Lumachi, F., Stellini, E., & Favero, L. (2013) · PubMed · Cited by 111
Hallmer, F., Andersson, G., Götrick, B., Warfvinge, G., Anderud, J., & Bjørnland, T. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.08.015 · Cited by 111
Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?
Atalay, B., Yalçın, S., Emes, Y., Aktaş, İ., Aybar, B., İşsever, H., Mandel, N. M., Çetin, Ö., & Öncü, B. (2011) · Lasers in Medical Science · doi:10.1007/s10103-011-0974-2 · Cited by 110
Fleisher, K. E., Welch, G., Kottal, S., Craig, R. G., Saxena, D. B., & Glickman, R. S. (2010) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2010.04.023 · Cited by 98
The use of bisphosphonates in the treatment of osteoporosis
Delmas, P. D. (2005) · Current Opinion in Internal Medicine · doi:10.1097/01.bor.0000163448.51661.87 · Cited by 97
de Castro, L. F., Burke, A. B., Wang, H. D., Tsai, J., Florenzano, P. F., Pan, K. S., Bhattacharyya, N., Boyce, A. M., Gafni, R. I., Molinolo, A., et al. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3602 · Cited by 97
Effect of Dental Implants on Bisphosphonate-Related Osteonecrosis of the Jaws
Holzinger, D., Seemann, R., Matoni, N., Ewers, R., Millesi, W., & Wutzl, A. (2014) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2014.04.037 · Cited by 93
Tooth extraction in patients on zoledronic acid therapy
Mozzati, M., Arata, V., & Gallesio, G. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.03.009 · Cited by 93
Ottesen, C., Schiødt, M., & Gotfredsen, K. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03795 · Cited by 92
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology
Fusco, V., Santini, D., Armento, G., Tonini, G., & Campisi, G. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1177021 · Cited by 91
Zhang, Q., Yu, W., Lee, S., Xu, Q., Naji, A., & Le, A. D. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2577 · Cited by 89
Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease
Soundia, A., Hadaya, D., Esfandi, N., de Molon, R. S., Bezouglaia, O., Dry, S., Pirih, F. Q. M., Aghaloo, T. L., & Tetradis, S. (2016) · Bone · doi:10.1016/j.bone.2016.06.011 · Cited by 89
Self-citationBonacina, R. M., Mariani, U., Villa, F., & Villa, A. (2011) · PubMed · Cited by 88
Giovannacci, I., Meleti, M., Manfredi, M., Mortellaro, C., Lucchina, A. G., Bonanini, M., & Vescovi, P. (2016) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000002564 · Cited by 87
Schubert, M., Klatte, I., Linek, W., Müller, B., Döring, K., Eckelt, U., Hemprich, A., Berger, U., & Hendricks, J. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.11.004 · Cited by 86
Valachis, A., Polyzos, N. P., Coleman, R. E., Gnant, M., Eidtmann, H., Brufsky, A., Aft, R., Tevaarwerk, A. J., Swenson, K. K., Lind, P., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0261 · Cited by 85
Gao, S., Lin, R., Huang, S.-H., Liang, Y., Li, X., Zhang, S., Ouyang, D., Li, K., Zheng, G., & Liao, G. (2019) · Bone · doi:10.1016/j.bone.2019.115117 · Cited by 84
Hennedige, A. A., Jayasinghe, J. A. P., Khajeh, J., & Macfarlane, T. V. (2013) · Journal of Oral and Maxillofacial Research · doi:10.5037/jomr.2013.4401 · Cited by 82
Nakamura, T., Fukunaga, M., Nakano, T., Kishimoto, H., Ito, M., Hagino, H., Sone, T., Taguchi, A., Tanaka, S., Ohashi, M., et al. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3736-y · Cited by 78
Intravenous bisphosphonate–related osteonecrosis of the jaw: Long-term follow-up of 109 patients
Watters, A. L., Hansen, H. J., Williams, T., et al. (2012) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2012.05.017 · Cited by 76
Ishtiaq, S., Edwards, S. F., Sankaralingam, A., Evans, B. A. J., Elford, C., Frost, M. L., Fogelman, I., & Hampson, G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.025 · Cited by 74
OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice
de Molon, R. S., Shimamoto, H., Bezouglaia, O., Pirih, F. Q. M., Dry, S., Kostenuik, P. J., Boyce, R. W., Dwyer, D., Aghaloo, T. L., & Tetradis, S. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2490 · Cited by 74
Self-citationSmidt-Hansen, T., Folkmar, T. B., Fode, K., Agerbæk, M., & Donskov, F. N. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.03.019 · Cited by 73
Miller, P. D., Pannacciulli, N., Malouf, J., Singer, A. J., Czerwinski, E. J., Bone, H. G., Wang, C., Huang, S., Chines, A. A., Lems, W. F., et al. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05233-x · Cited by 73
Osteonecrosis of the jaw – Prevention and treatment strategies for oral health professionals
Hinchy, N. V., Jayaprakash, V., Rossitto, R., Anders, P. L., Korff, K. C., Canallatos, P., & Sullivan, M. A. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.06.008 · Cited by 72
Patel, V., McLeod, N. M. H., Rogers, S. N., & Brennan, P. A. (2010) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2010.05.007 · Cited by 72
Kim, T., Kim, S., Song, M., Lee, C., Yagita∥, H., Williams, D. W., SUNG, E. C., Hong, C., Shin, K.-H., Kang, M., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.06.019 · Cited by 71
Preventive Protocol for Tooth Extractions in Patients Treated With Zoledronate: A Case Series
Ferlito, S., Puzzo, S., & Liardo, C. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2010.10.055 · Cited by 68
Bodem, J. P., Kargus, S., Eckstein, S., Saure, D., Engel, M., Hoffmann, J., & Freudlsperger, C. (2015) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2015.02.018 · Cited by 66
Dayısoylu, E. H., Şenel, F., Üngör, C., Tosun, E., Çankaya, M., Ersöz, Ş., & Taşkesen, F. (2013) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2013.05.001 · Cited by 66
Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review
Gelažius, R., Poškevičius, L., Sakavičius, D., Grimuta, V., & Juodžbalys, G. (2018) · Journal of Oral and Maxillofacial Research · doi:10.5037/jomr.2018.9302 · Cited by 64
de Molon, R. S., Cheong, S., Bezouglaia, O., Dry, S., Pirih, F. Q. M., Cirelli, J. A., Aghaloo, T. L., & Tetradis, S. (2014) · Bone · doi:10.1016/j.bone.2014.07.027 · Cited by 63
Self-citationMaines, E., Monti, E., Doro, F., Morandi, G., Cavarzere, P., & Antoniazzi, F. (2011) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-011-0331-3 · Cited by 61
Shudo, A., Kishimoto, H., Takaoka, K., & Noguchi, K. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4621-7 · Cited by 61
Giudice, A., Barone, S., Diodati, F., Antonelli, A., Nocini, R., & Cristofaro, M. G. (2020) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2020.05.037 · Cited by 61
Recreo, P. B., de Vera, J. L. D. C. P., Georgiev-Hristov, T., Bravo-Burguillos, E. R., Abarrategi, A., Burgueño, M., & García‐Arranz, M. (2015) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2015.04.026 · Cited by 60
Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review
Ng, T. L., Tu, M. M., Ibrahim, M. F. K., Basulaiman, B. M., McGee, S. F., Srikanthan, A., Fernandes, R., Vandermeer, L., Stober, C., Sienkiewicz, M., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05556-0 · Cited by 60
Wang, X., Yang, K., Wanyan, P., & Tian, J. H. (2014) · Oncology Letters · doi:10.3892/ol.2014.1982 · Cited by 58
Varoni, E. M., Lombardi, N., Villa, G., Pispero, A., Sardella, A., & Lodi, G. (2021) · Antibiotics · doi:10.3390/antibiotics10020195 · Cited by 58
Kuroshima, S., Entezami, P., McCauley, L. K., & Yamashita, J. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2570-8 · Cited by 57
Musolino, C., Oteri, G., Allegra, A., Mania, M., D’Ascola, A., Avenoso, A., Innao, V., Allegra, A. G., & Campo, S. (2018) · Annals of Hematology · doi:10.1007/s00277-018-3296-7 · Cited by 56
Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ)
Gkouveris, I., Hadaya, D., Soundia, A., Bezouglaia, O., Chau, Y., Dry, S., Pirih, F. Q. M., Aghaloo, T. L., & Tetradis, S. (2019) · Bone · doi:10.1016/j.bone.2019.03.031 · Cited by 55
Self-citationPalmisano, B., Spica, E., Remoli, C., Labella, R., Filippo, A. D., Donsante, S., Bini, F., Raimondo, D., Marinozzi, F., BOYDE, A., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3828 · Cited by 55
Bisphosphonates for advanced prostate cancer
Macherey‐Meyer, S., Monsef, I., Jahn, F., Jordan, K., Yuen, K.-K., Heidenreich, A., & Skoetz, N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006250.pub2 · Cited by 54
de Molon, R. S., Hsu, C., Bezouglaia, O., Dry, S., Pirih, F. Q. M., Soundia, A., Cunha, F. Q., Cirelli, J. A., Aghaloo, T. L., & Tetradis, S. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2827 · Cited by 53
Self-citationNonsurgical Management of Medication-Related Osteonecrosis of the Jaws Using Local Wound Care
Hadaya, D., Soundia, A., FREYMILLER, E. G., Grogan, T., Elashoff, D. A., Tetradis, S., & Aghaloo, T. L. (2018) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2018.05.025 · Cited by 53
Self-citationBisphosphonates and their clinical implications in endodontic therapy
Moinzadeh, A. T., Shemesh, H., Neirynck, N., Aubert, C., & Wesselink, P. R. (2012) · International Endodontic Journal · doi:10.1111/iej.12018 · Cited by 49
Carlson, E. R., Fleisher, K. E., & Ruggiero, S. L. (2013) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2013.05.014 · Cited by 48
Self-citationCan children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review
Duarte, N. T., Rech, B. D. O., Martins, I. G., Franco, J. B., & Ortega, K. L. (2019) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2019.08.004 · Cited by 47
Sacco, R., Shah, S., Leeson, R., Moraschini, V., Mourão, C. F., Akintola, O., & Lalli, A. (2019) · British Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.bjoms.2019.09.023 · Cited by 47
Terpos, E., Raje, N. S., Croucher, P. I., García‐Sánz, R., Leleu, X. P., Pasteiner, W., Wang, Y., Glennane, A., Canon, J. R., & Pawlyn, C. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002378 · Cited by 45
Yang, G., Hamadeh, I. S., Katz, J., Riva, A., Lakatos, P. L., Balla, B., Kosa, J. P., Vaszilkó, M., Pelliccioni, G. A., Davis, N., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3285 · Cited by 44
Granate-Marques, A., Polis-Yanes, C., Seminario-Amez, M., et al. (2019) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.22691 · Cited by 43
Wehrhan, F., Groß, C., Creutzburg, K., Amann, K., Ries, J., Kesting, M. R., Geppert, C., & Weber, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1819-1 · Cited by 42
Akita, Y., Kuroshima, S., Nakajima, K., Hayano, H., Kanai, R., Sasaki, M., & Sawase, T. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0872-1 · Cited by 37
Rodríguez‐Lozano, F. J., Sánchez, R. E. O., Gonzálvez-García, M., Bergadá, M. V., Martínez, C. M., Revilla‐Nuin, B., Gironés, J. G., Moraleda, J. M., & García‐Bernal, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061649 · Cited by 37
Guo, Z., Cui, W., Que, L., Li, C., Tang, X., & Liu, J. (2019) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2019.07.016 · Cited by 35
Lee, K. H., Kim, S., Kim, C. H., Min, B. J., Kim, G. J., Lim, Y., Kim, H., Ahn, K., & Kim, J. H. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2129-3 · Cited by 34
Morishita, K., Yamada, S., Kawakita, A., Hashidume, M., Tachibana, A., Takeuchi, N., Ohbayashi, Y., Kanno, T., Yoshiga, D., Narai, T., et al. (2020) · Journal of Orthopaedic Science · doi:10.1016/j.jos.2020.01.012 · Cited by 34
Lorenzo‐Pouso, A. I., Pérez‐Sayáns, M., González‐Palanca, S., Chamorro-Petronacci, C. M., Sebastián, J. V. B., & García, A. G. (2018) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.22763 · Cited by 33
Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab
Francini, F., Pascucci, A., Francini, E., Miano, S. T., Bargagli, G., Ruggiero, G., & Petrioli, R. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0220 · Cited by 32
Stopeck, A., Brufsky, A., Kennedy, L., Bhatta, S., Bhowmik, D., Buchanan, J., Despiégel, N., & Hechmati, G. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1651122 · Cited by 32
Jeon, H., Oh, I., Baek, Y., Yang, H., Park, J., Hong, S., & Shin, J. (2019) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-019-01052-6 · Cited by 31
Messer, J. G., Jiron, J. M., Calle, J. L. M., Castillo, E. J., Israel, R., Phillips, E. G., Yarrow, J. F., Poznak, C. H. V., Kesavalu, L. N., Kimmel, D. B., et al. (2019) · Oral Diseases · doi:10.1111/odi.13052 · Cited by 28
Bisphosphonates and breast cancer – From cautious palliation to saving lives
Coleman, R. E. (2020) · Bone · doi:10.1016/j.bone.2020.115570 · Cited by 28
SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw
Yang, G., Collins, J. M., Rafiee, R., Singh, S., Langaee, T. Y., McDonough, C. W., Holliday, L. S., Wang, D., Lamba, J. K., Kim, Y. S., et al. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4185 · Cited by 27
Alonso-Rodriguez, E., Gonzalez, J., Carretero, J. L. C., Castillo, J. D., Pozo‐Kreilinger, J. J., Ruiz‐Bravo, E., García‐Arranz, M., Hernández-Godoy, J., & Burgueño, M. (2019) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.22959 · Cited by 26
Kuroshima, S., Nakajima, K., Sasaki, M., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1308-8 · Cited by 26
Kastritis, E., Melea, P., Bagratuni, T., Melakopoulos, I., Gavriatopoulou, M., Ρούσσου, Μ., Migkou, M., Eleutherakis‐Papaiakovou, E., Terpos, E., & Dimopoulos, M. A. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1300889 · Cited by 24
Yang, R., Tao, Y., Wang, C., Shuai, Y., & Jin, L. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.27593 · Cited by 23
Antiresorptive-Type and Discontinuation-Timing Affect ONJ Burden
Hadaya, D., Soundia, A., Gkouveris, I., Bezouglaia, O., Dry, S., Pirih, F. Q. M., Aghaloo, T. L., & Tetradis, S. (2021) · Journal of Dental Research · doi:10.1177/0022034520986804 · Cited by 23
Self-citationGossiel, F., Paggiosi, M., Naylor, K. E., McCloskey, E. V., Walsh, J., Peel, N. F. A., & Eastell, R. (2019) · Bone · doi:10.1016/j.bone.2019.115158 · Cited by 21
Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy
Fleisher, K. E., Janal, M. N., Albstein, N., Young, J., Bikhazi, V., Schwalb, S., Wolff, M. S., & Glickman, R. S. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.09.012 · Cited by 18
Pharmacologic management of metastatic bone disease
Schwartz, E. B., Reichert, Z. R., & Poznak, C. H. V. (2020) · Bone · doi:10.1016/j.bone.2020.115735 · Cited by 15
Individualized Bone-Protective Management in Long-Term Cancer Survivors With Bone Metastases
Rachner, T. D., Coleman, R. E., Hadji, P., & Hofbauer, L. C. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4391 · Cited by 14
Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw
Chopra, K., & Malhan, N. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001182 · Cited by 10
Kanis, J. А., Harvey, N. C., Lorentzon, M., Liu, E., Vandenput, L., McCloskey, E. V., & Johansson, H. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05699-0 · Cited by 10
Yang, Y., Xiang, Z.-J., Yang, J.-H., Wang, W., & Xiang, R. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919855235 · Cited by 9
Metadata
- Authors
- Ruggiero, S. L., Dodson, T. B., Aghaloo, T., Carlson, E. R., Ward, B. B., & Kademani, D.
- Venue
- Journal of Oral and Maxillofacial Surgery
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 80
- Issue
- 5
- Pages
- 920-943
- ISSN
- 0278-2391 (ISSN-L)
- OpenAlex
- W4213264012
- Cited by
- 1,141
- References
- 184
- FWCI
- 79.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.